Skip to content 
Type 2 Diabetes Clinical Trials: What Patients in Arizona Need to Know
More than 37 million Americans live with Type 2 diabetes. The next generation of Type 2 diabetes clinical trials is
being tested right now — and patients like you are helping make it happen.
Type 2 diabetes is one of the most researched conditions in medicine, fueling a growing number of Type 2 diabetes clinical trials — and for good reason. It is the fastest-growing chronic disease in the United States, affecting more than 37 million Americans and millions more who do not yet know they have it.
Despite decades of progress, many patients still struggle to reach their target blood sugar levels. Side effects from medications, weight gain, and fatigue make adherence difficult.
As a result, pharmaceutical companies are investing billions in developing new diabetes therapies, and clinical trials enrolling people with Type 2 diabetes are taking place across the country at an unprecedented pace.
What Type 2 Diabetes Clinical Trials Are Trying to Solve
The medications used most widely for Type 2 diabetes today — metformin, GLP-1 receptor agonists (i.e. semaglutide), SGLT-2 inhibitors (i.e. Jardiance) – were all tested in clinical research within the past few decades. Each generation of research has given physicians better tools. Current trials are pushing further:
- Combination therapies that lower blood sugar and promote weight loss simultaneously
- Once-weekly or once-monthly injectable options to reduce the burden of daily medication
- Treatments that specifically target insulin resistance — the root cause of Type 2 diabetes — rather than just managing blood sugar
- Drugs that protect the heart and kidneys, which are often damaged by long-term uncontrolled diabetes
37M+ million Americans living with Type 2 diabetes — and 110+ million more with prediabetes who are at high risk.
What Participating in a Diabetes Clinical Trial Actually Looks Like
If you are curious about what joining a diabetes clinical trial involves, here is a realistic picture of the experience
at a community research site like Mission Research Institute:
After a brief phone pre-screening to confirm basic eligibility, you come in for a free screening visit. A study physician will review your diabetes history, current medications, and recent labs. Additional blood work is collected. If you qualify and choose to enroll, you receive the investigational treatment at no cost — along with regular monitoring visits where your A1C, blood sugar, weight, and other markers are tracked closely. Most diabetes studies require visits every few weeks at first, then monthly. Each visit typically lasts one – two hours. You are compensated for your time and travel. If anything changes you can withdraw at any time.
Who Qualifies for Type 2 Diabetes Clinical Trials
- Have a confirmed Type 2 diabetes diagnosis
- Have an HbA1c in a specific range (often between 7.0% and 10.5%)
- Are on a stable dose of one or more diabetes medications — or newly diagnosed and not yet on medication
- Do not have certain other medical conditions that would make participation unsafe
The Benefit Beyond the Study Drug
Many patients who join diabetes clinical trials report an unexpected benefit: they become more engaged in their own diabetes management. Regular monitoring visits, access to detailed lab results, and the close attention of a dedicated research team create a level of accountability and support that routine care often cannot match.
This is not a replacement for your primary care physician. Our research team works alongside your regular doctor — not instead of them.
